Article(id=1329914615149998236, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.08.018, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1716912000000, receivedDateStr=2024-05-29, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005952869, onlineDateStr=2026-11-18, pubDate=1723219200000, pubDateStr=2024-08-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005952869, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005952869, creator=13701087609, updateTime=1795005952869, updator=13701087609, issue=Issue{id=1329914534925545632, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='8', pageStart='1045', pageEnd='1169', issueExtLink='null', onlineDate='null', pubDate='1723219200000', pubDateStr='2024-08-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005933743, creator='13701087609', updateTime=1795136196326, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460896280818483, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460896280818484, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914534925545632, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1156, endPage=1162, ext={EN=ArticleExt(id=1329914615410045085, articleId=1329914615149998236, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Key Production Process Points and Marketed Cases Analysis of Recombinant Adeno-associated Virus Products, columnId=1329914608015487047, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Development and Production Quality Control of Gene Drugs, runingTitle=null, highlight=null, articleAbstract=null, authors=Chengjie SUN, Yang ZHUO*, authorsList=Chengjie SUN, Yang ZHUO, authorCompany=null, correspAuthors=Yang ZHUO, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914616269877406, articleId=1329914615149998236, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=重组腺相关病毒产品的生产工艺要点及已上市案例分析, columnId=1329914608187453513, journalTitle=中国医药工业杂志, columnName=基因药物的开发与生产质量控制专栏, runingTitle=null, highlight=null, articleAbstract=

重组腺相关病毒产品为经设计和重组改造所形成的、用于携带外源目的基因(或核酸片段)的病毒载体,属于体内基因治疗产品,其生产平台常见的主要有三质粒瞬转系统及昆虫细胞/杆状病毒系统。该文重点梳理了重组腺相关病毒产品的生产平台技术特点、优势、劣势以及上下游工艺要点并结合实例分析,以期为该类产品的生产实践、质量管理、上市监管提供理论指导。

, authors=孙程洁, 卓阳*, authorsList=孙程洁, 卓阳, authorCompany=null, correspAuthors=卓阳, authorNote=

孙程洁(1993—),女,工程师,从事生物制品监管的研究。

, correspAuthorsNote=
卓阳(1984—),女,硕士,工程师,从事药品注册管理的研究。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=5D3FQdfQla/Zs7mtJ9WoSA==, magXml=MXF9jlKnPtzGsXuu2lBX3Q==, pdfUrl=null, pdf=ffL35EKT1LuvkwSK4R4dbg==, pdfFileSize=2191912, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=Nm43rwpgCmx3T7rwmwk15Q==, mapNumber=null, fund=null)}, authors=[Author(id=1329914616588644515, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914616672530597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616588644515, language=EN, stringName=Chengjie SUN, firstName=Chengjie, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914616752222374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616588644515, language=CN, stringName=孙程洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海药品审评核查中心,上海 201203, bio={"content":"

孙程洁(1993—),女,工程师,从事生物制品监管的研究。

"}, bioImg=null, bioContent=

孙程洁(1993—),女,工程师,从事生物制品监管的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914616504758431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, xref=null, ext=[AuthorCompanyExt(id=1329914616513147040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914616525729953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海药品审评核查中心,上海 201203)])]), Author(id=1329914616819331240, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhuoyang@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914616907411626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616819331240, language=EN, stringName=Yang ZHUO, firstName=Yang, middleName=null, lastName=ZHUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914616974520491, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616819331240, language=CN, stringName=卓阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914616504758431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, xref=null, ext=[AuthorCompanyExt(id=1329914616513147040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914616525729953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海药品审评核查中心,上海 201203)])])], keywords=[Keyword(id=1329914617058406572, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, language=CN, orderNo=1, keyword=腺相关病毒), Keyword(id=1329914617125515437, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, language=CN, orderNo=2, keyword=基因治疗), Keyword(id=1329914617192624302, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, language=CN, orderNo=3, keyword=生产工艺), Keyword(id=1329914617251344559, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, language=CN, orderNo=4, keyword=重组)], refs=[Reference(id=1329914617339424944, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=PETRS-SILVA H, LINDEN R.Advances in recombinant adeno-associated viral vectors for gene delivery [J].Curr Gene Ther, 2013, 13(5): 335-345., articleTitle=null, refAbstract=null), Reference(id=1329914617410728113, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=SU W, PATRÍCIO M I, DUFFY M R, et al.Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination [J].Nat Commun, 2022, 13(1): 1182., articleTitle=null, refAbstract=null), Reference(id=1329914617490419890, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.体内基因治疗产品药学研究与评价技术指导原则(试行)[EB/OL].(2022-05-31)[2023-12-07].https://www.cde.org.cn/main/news/viewInfoCommon/c0ec5e347ba84df67bf75e15f6ad3f3f., articleTitle=null, refAbstract=null), Reference(id=1329914617570111667, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.基因治疗产品非临床研究与评价技术指导原则(试行)[EB/OL].(2021-12-03)[2023-12-07].https://www.cde.org.cn/main/news/viewInfoCommon/41bc557bec23a6ebfb0e148cc989f041., articleTitle=null, refAbstract=null), Reference(id=1329914617649803444, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.罕见病基因治疗产品临床试验技术指导原则(试行)[EB/OL].(2024-01-18)[2024-05-29].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=a5c62d069700ed3bfbf9f7ab-6c7aca7d., articleTitle=null, refAbstract=null), Reference(id=1329914617716912309, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=SRIVASTAVA A, MALLELA K M G, DEORKAR N, et al.Manufacturing challenges and rational formulation development for AAV viral vectors [J].J Pharm Sci, 2021, 110(7): 2609-2624., articleTitle=null, refAbstract=null), Reference(id=1329914617804992695, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=DOBROWSKY T, GIANNI D, PIERACCI J, et al.AAV manufacturing for clinical use: insights on current challenges from the upstream process perspective [J].Curr Opin Biomed Eng, 2021, 20: 100353., articleTitle=null, refAbstract=null), Reference(id=1329914617884684472, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=PEZZOLI D, GIUPPONI E, MANTOVANI D, et al.Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation [J].Sci Rep, 2017, 7: 44134., articleTitle=null, refAbstract=null), Reference(id=1329914617960181946, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=WU Y, JIANG L Y, GENG H, et al.A recombinant baculovirus efficiently generates recombinant adeno-associated virus vectors in cultured insect cells and larvae [J].Mol Ther Methods Clin Dev, 2018, 10: 38-47., articleTitle=null, refAbstract=null), Reference(id=1329914618031485115, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=MIETZSCH M, CASTELEYN V, WEGER S, et al.OneBac 2.0: Sf9 cell lines for production of AAV5 vectors with enhanced infectivity and minimal encapsidation of foreign DNA [J].Hum Gene Ther, 2015, 26(10): 688-697., articleTitle=null, refAbstract=null), Reference(id=1329914618148925629, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=JOSHI P R H, CERVERA L, AHMED I, et al.Achieving high-yield production of functional AAV5 gene delivery vectors via fedbatch in an insect cell-one baculovirus system [J].Mol Ther Methods Clin Dev, 2019, 13: 279-289., articleTitle=null, refAbstract=null), Reference(id=1329914618216034494, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=GUAN J S, CHEN K, SI Y N, et al.Process improvement of adeno-associated virus(AAV) production [J].Front Chem Eng, 2022, 4: 830421., articleTitle=null, refAbstract=null), Reference(id=1329914618278949055, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.Considerations for plasmid DNA vaccines for infectious disease indications [EB/OL].[2023-12-07].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-plasmid-dna-vaccines-infectious-disease-indications., articleTitle=null, refAbstract=null), Reference(id=1329914618333475008, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=GRIEGER J C, SOLTYS S M, SAMULSKI R J.Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector[J].Mol Ther, 2016, 24(2): 287-297., articleTitle=null, refAbstract=null), Reference(id=1329914620288020673, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=CERVERA L, FUENMAYOR J, GONZÁLEZ-DOMÍNGUEZ I,et al.Selection and optimization of transfection enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures [J].Appl Microbiol Biotechnol, 2015, 99(23): 9935-9949., articleTitle=null, refAbstract=null), Reference(id=1329914620380295362, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=WRIGHT J F.Product-related impurities in clinical-grade recombinant AAV vectors: characterization and risk assessment [J].Biomedicines, 2014, 2(1): 80-97., articleTitle=null, refAbstract=null), Reference(id=1329914620447404227, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=MIETZSCH M, SMITH J K, YU J C, et al.Characterization of AAV-specific affinity ligands: consequences for vector purification and development strategies [J].Mol Ther Methods Clin Dev, 2020, 19: 362-373., articleTitle=null, refAbstract=null), Reference(id=1329914620518707396, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=HAJBA L, GUTTMAN A.Recent advances in the analysis full/empty capsid ratio and genome integrity of adeno-associated virus(AAV) gene delivery vectors [J].Curr Mol Med, 2020, 20(10): 806-813., articleTitle=null, refAbstract=null), Reference(id=1329914620590010565, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=FDA.CBER CMC BLA review memo—ELEVIDYS [EB/OL].(2023-07-13)[2023-12-07].https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/elevidys., articleTitle=null, refAbstract=null), Reference(id=1329914620665508038, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=CBER FDA.CBER-DMPQ CMC-facility BLA review memo—ELEVIDYS [EB /OL].(2023-07-13)[2023-12-07].https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/elevidys., articleTitle=null, refAbstract=null), Reference(id=1329914620728422599, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=CBER FDA.Clinical review memo – ELEVIDYS [EB /OL].(2023-07-13) [2023-12-07].https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/elevidys., articleTitle=null, refAbstract=null), Reference(id=1329914620787142856, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Sarepta Therapeutics.Sarepta Therapeutics announces positive vote from U.S. FDA advisory committee meeting for SRP-9001 gene therapy to treat duchenne muscular dystrophy [EB/OL].(2023-05-23)[2023-12-07].https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-positive-vote-us-fda-advisory., articleTitle=null, refAbstract=null), Reference(id=1329914620854251721, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=SU W H, PATRÍCIO M I, DUFFY M R, et al.Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination [J].Nat Commun, 2022, 13(1): 1182., articleTitle=null, refAbstract=null), Reference(id=1329914620921360586, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=LI C W, SAMULSKI R J.Engineering adeno-associated virus vectors for gene therapy [J].Nat Rev Genet, 2020, 21(4): 255-272., articleTitle=null, refAbstract=null), Reference(id=1329914621026218187, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局药品审评中心.关于发布《重组腺相关病毒载体类体内基因治疗产品临床试验申请药学研究与评价技术指导原则》的通告(2024年第8号)[EB/OL].(2024-01-17) [2024-05-29].https://www.cde.org.cn/main/news/viewInfoCommon/635323ee319daca-b26eb783b843b8bd3., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914616504758431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, xref=null, ext=[AuthorCompanyExt(id=1329914616513147040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914616525729953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海药品审评核查中心,上海 201203)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.08.018, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.08.018, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.08.018, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.08.018, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1723219200000, fullTextJson=null, articleText=null, reference=null)
收藏切换
重组腺相关病毒产品的生产工艺要点及已上市案例分析
孙程洁 , 卓阳 *
中国医药工业杂志 | 基因药物的开发与生产质量控制专栏 2024,55(8): 1156-1162
收起
收藏切换
中国医药工业杂志 |基因药物的开发与生产质量控制专栏 2024 , 55 (8) : 1156 -1162
重组腺相关病毒产品的生产工艺要点及已上市案例分析
全屏
[Author(id=1329914616588644515, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914616672530597, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616588644515, language=EN, stringName=Chengjie SUN, firstName=Chengjie, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914616752222374, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616588644515, language=CN, stringName=孙程洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海药品审评核查中心,上海 201203, bio={"content":"

孙程洁(1993—),女,工程师,从事生物制品监管的研究。

"}, bioImg=null, bioContent=

孙程洁(1993—),女,工程师,从事生物制品监管的研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914616504758431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, xref=null, ext=[AuthorCompanyExt(id=1329914616513147040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914616525729953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海药品审评核查中心,上海 201203)])]), Author(id=1329914616819331240, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=zhuoyang@smda.sh.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914616907411626, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616819331240, language=EN, stringName=Yang ZHUO, firstName=Yang, middleName=null, lastName=ZHUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914616974520491, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, authorId=1329914616819331240, language=CN, stringName=卓阳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海药品审评核查中心,上海 201203, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914616504758431, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, xref=null, ext=[AuthorCompanyExt(id=1329914616513147040, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203), AuthorCompanyExt(id=1329914616525729953, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914615149998236, companyId=1329914616504758431, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海药品审评核查中心,上海 201203)])])]
孙程洁, 卓阳*
作者信息
  • 上海药品审评核查中心,上海 201203
通讯作者:
卓阳(1984—),女,硕士,工程师,从事药品注册管理的研究。E-mail:
作者简介:

孙程洁(1993—),女,工程师,从事生物制品监管的研究。

Key Production Process Points and Marketed Cases Analysis of Recombinant Adeno-associated Virus Products
Chengjie SUN, Yang ZHUO*
Affiliations
  • Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203
出版时间: 2024-08-10 doi: 10.16522/j.cnki.cjph.2024.08.018
文章导航
收藏切换

重组腺相关病毒产品为经设计和重组改造所形成的、用于携带外源目的基因(或核酸片段)的病毒载体,属于体内基因治疗产品,其生产平台常见的主要有三质粒瞬转系统及昆虫细胞/杆状病毒系统。该文重点梳理了重组腺相关病毒产品的生产平台技术特点、优势、劣势以及上下游工艺要点并结合实例分析,以期为该类产品的生产实践、质量管理、上市监管提供理论指导。

腺相关病毒  /  基因治疗  /  生产工艺  /  重组
孙程洁, 卓阳. 重组腺相关病毒产品的生产工艺要点及已上市案例分析. 中国医药工业杂志, 2024 , 55 (8) : 1156 -1162 . DOI: 10.16522/j.cnki.cjph.2024.08.018
Chengjie SUN, Yang ZHUO. Key Production Process Points and Marketed Cases Analysis of Recombinant Adeno-associated Virus Products[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (8) : 1156 -1162 . DOI: 10.16522/j.cnki.cjph.2024.08.018

参考文献 引证文献
排序方式:
[1]
PETRS-SILVA H, LINDEN R.Advances in recombinant adeno-associated viral vectors for gene delivery [J].Curr Gene Ther, 2013, 13(5): 335-345.
[2]
SU W, PATRÍCIO M I, DUFFY M R, et al.Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination [J].Nat Commun, 2022, 13(1): 1182.
[3]
国家药品监督管理局药品审评中心.体内基因治疗产品药学研究与评价技术指导原则(试行)[EB/OL].(2022-05-31)[2023-12-07].https://www.cde.org.cn/main/news/viewInfoCommon/c0ec5e347ba84df67bf75e15f6ad3f3f.
[4]
国家药品监督管理局药品审评中心.基因治疗产品非临床研究与评价技术指导原则(试行)[EB/OL].(2021-12-03)[2023-12-07].https://www.cde.org.cn/main/news/viewInfoCommon/41bc557bec23a6ebfb0e148cc989f041.
[5]
国家药品监督管理局药品审评中心.罕见病基因治疗产品临床试验技术指导原则(试行)[EB/OL].(2024-01-18)[2024-05-29].https://www.cde.org.cn/zdyz/domesticinfopage?zdyzIdCODE=a5c62d069700ed3bfbf9f7ab-6c7aca7d.
[6]
SRIVASTAVA A, MALLELA K M G, DEORKAR N, et al.Manufacturing challenges and rational formulation development for AAV viral vectors [J].J Pharm Sci, 2021, 110(7): 2609-2624.
[7]
DOBROWSKY T, GIANNI D, PIERACCI J, et al.AAV manufacturing for clinical use: insights on current challenges from the upstream process perspective [J].Curr Opin Biomed Eng, 2021, 20: 100353.
[8]
PEZZOLI D, GIUPPONI E, MANTOVANI D, et al.Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation [J].Sci Rep, 2017, 7: 44134.
[9]
WU Y, JIANG L Y, GENG H, et al.A recombinant baculovirus efficiently generates recombinant adeno-associated virus vectors in cultured insect cells and larvae [J].Mol Ther Methods Clin Dev, 2018, 10: 38-47.
[10]
MIETZSCH M, CASTELEYN V, WEGER S, et al.OneBac 2.0: Sf9 cell lines for production of AAV5 vectors with enhanced infectivity and minimal encapsidation of foreign DNA [J].Hum Gene Ther, 2015, 26(10): 688-697.
[11]
JOSHI P R H, CERVERA L, AHMED I, et al.Achieving high-yield production of functional AAV5 gene delivery vectors via fedbatch in an insect cell-one baculovirus system [J].Mol Ther Methods Clin Dev, 2019, 13: 279-289.
[12]
GUAN J S, CHEN K, SI Y N, et al.Process improvement of adeno-associated virus(AAV) production [J].Front Chem Eng, 2022, 4: 830421.
[13]
FDA.Considerations for plasmid DNA vaccines for infectious disease indications [EB/OL].[2023-12-07].https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-plasmid-dna-vaccines-infectious-disease-indications.
[14]
GRIEGER J C, SOLTYS S M, SAMULSKI R J.Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector[J].Mol Ther, 2016, 24(2): 287-297.
[15]
CERVERA L, FUENMAYOR J, GONZÁLEZ-DOMÍNGUEZ I,et al.Selection and optimization of transfection enhancer additives for increased virus-like particle production in HEK293 suspension cell cultures [J].Appl Microbiol Biotechnol, 2015, 99(23): 9935-9949.
[16]
WRIGHT J F.Product-related impurities in clinical-grade recombinant AAV vectors: characterization and risk assessment [J].Biomedicines, 2014, 2(1): 80-97.
[17]
MIETZSCH M, SMITH J K, YU J C, et al.Characterization of AAV-specific affinity ligands: consequences for vector purification and development strategies [J].Mol Ther Methods Clin Dev, 2020, 19: 362-373.
[18]
HAJBA L, GUTTMAN A.Recent advances in the analysis full/empty capsid ratio and genome integrity of adeno-associated virus(AAV) gene delivery vectors [J].Curr Mol Med, 2020, 20(10): 806-813.
[19]
FDA.CBER CMC BLA review memo—ELEVIDYS [EB/OL].(2023-07-13)[2023-12-07].https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/elevidys.
[20]
CBER FDA.CBER-DMPQ CMC-facility BLA review memo—ELEVIDYS [EB /OL].(2023-07-13)[2023-12-07].https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/elevidys.
[21]
CBER FDA.Clinical review memo – ELEVIDYS [EB /OL].(2023-07-13) [2023-12-07].https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/elevidys.
[22]
Sarepta Therapeutics.Sarepta Therapeutics announces positive vote from U.S. FDA advisory committee meeting for SRP-9001 gene therapy to treat duchenne muscular dystrophy [EB/OL].(2023-05-23)[2023-12-07].https://investorrelations.sarepta.com/news-releases/news-release-details/sarepta-therapeutics-announces-positive-vote-us-fda-advisory.
[23]
SU W H, PATRÍCIO M I, DUFFY M R, et al.Self-attenuating adenovirus enables production of recombinant adeno-associated virus for high manufacturing yield without contamination [J].Nat Commun, 2022, 13(1): 1182.
[24]
LI C W, SAMULSKI R J.Engineering adeno-associated virus vectors for gene therapy [J].Nat Rev Genet, 2020, 21(4): 255-272.
[25]
国家药品监督管理局药品审评中心.关于发布《重组腺相关病毒载体类体内基因治疗产品临床试验申请药学研究与评价技术指导原则》的通告(2024年第8号)[EB/OL].(2024-01-17) [2024-05-29].https://www.cde.org.cn/main/news/viewInfoCommon/635323ee319daca-b26eb783b843b8bd3.
2024年第55卷第8期
24
7
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.08.018
  • 接收时间:2024-05-29
  • 首发时间:2026-11-18
  • 出版时间:2024-08-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2024-05-29
基金
作者信息
    上海药品审评核查中心,上海 201203

通讯作者:

卓阳(1984—),女,硕士,工程师,从事药品注册管理的研究。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.08.018
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏